Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02693353 · ClinicalTrials.gov registry record
Epiretinal Membrane and Pseudophakic Cystoid Macular Edema
A clinical trial, sponsored by Loma Linda University.
- Terminated
- Registry status
- 52
- Enrollment target
NCT02693353: Clinical Trial study, sponsored by Loma Linda University.
NCT02693353 is a clinical trial that was terminated before completion, run by Loma Linda University. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02693353 was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- 52 participants
- Enrollment target
Study Summary
Prospective, observational cohort study evaluating the association between pre-surgical existence of an epiretinal membrane (ERM) and the development of pseudophakic cystoid macular edema (PCME) using spectral domain optical coherence tomography (OCT) measurements.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-03 |
Why NCT02693353 stopped before completion
NCT02693353 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02693353 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02693353 about?
NCT02693353 is a clinical study titled "Epiretinal Membrane and Pseudophakic Cystoid Macular Edema". Prospective, observational cohort study evaluating the association between pre-surgical existence of an epiretinal membrane (ERM) and the development of pseudophakic cystoid macular edema (PCME) using spectral domain optical coherence tomography (OCT) measurements.
What is the current status of trial NCT02693353?
This trial is currently terminated. The enrollment target is 52 participants. The study started on 2016-02. Estimated completion is 2019-03.
Who is sponsoring clinical trial NCT02693353?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia